Ligand validation:2YPO

PHE: PHENYLALANINE

PHE is a Ligand Of Interest in 2YPO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YPO_PHE_B_900	81%	39%	0.09	0.943	1.4	1.03	2	1	0	0	100%	1
2YPO_PHE_A_900	81%	56%	0.093	0.946	0.56	1.11	-	2	0	0	100%	1
3KGF_PHE_A_9003	80%	56%	0.094	0.944	0.73	0.97	-	1	0	0	100%	1
3NUD_PHE_A_465	50%	54%	0.224	0.978	0.81	0.96	1	2	0	0	100%	1
5CKV_PHE_A_509	35%	55%	0.242	0.934	0.72	1.01	1	2	1	0	100%	0.91
3RZI_PHE_B_465	16%	59%	0.29	0.865	0.74	0.8	1	1	0	0	100%	0.75
5DCB_PHE_D_405	94%	60%	0.073	0.97	0.92	0.61	1	-	0	0	100%	1
3DES_PHE_B_412	93%	67%	0.073	0.969	0.73	0.54	-	-	1	0	100%	1
6YU3_PHE_A_703	92%	52%	0.089	0.98	1.1	0.76	1	-	0	0	100%	1
8P8X_PHE_A_501	90%	40%	0.087	0.968	1.37	1.04	1	1	0	0	100%	1
4JPX_PHE_A_301	89%	52%	0.071	0.948	0.77	1.08	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.